3-hydroxypregn-4-en-20-one has been researched along with dactinomycin in 1 studies
Studies (3-hydroxypregn-4-en-20-one) | Trials (3-hydroxypregn-4-en-20-one) | Recent Studies (post-2010) (3-hydroxypregn-4-en-20-one) | Studies (dactinomycin) | Trials (dactinomycin) | Recent Studies (post-2010) (dactinomycin) |
---|---|---|---|---|---|
29 | 0 | 2 | 19,045 | 355 | 969 |
Protein | Taxonomy | 3-hydroxypregn-4-en-20-one (IC50) | dactinomycin (IC50) |
---|---|---|---|
RAD51 | Homo sapiens (human) | 32.1 | |
Growth factor receptor-bound protein 2 | Homo sapiens (human) | 5 | |
Discoidin domain-containing receptor 2 | Homo sapiens (human) | 9 | |
Growth factor receptor-bound protein 2 | Mus musculus (house mouse) | 5 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Pawlak, KJ; Wiebe, JP; Zhang, G | 1 |
1 other study(ies) available for 3-hydroxypregn-4-en-20-one and dactinomycin
Article | Year |
---|---|
Membrane 5alpha-pregnane-3,20-dione (5alphaP) receptors in MCF-7 and MCF-10A breast cancer cells are up-regulated by estradiol and 5alphaP and down-regulated by the progesterone metabolites, 3alpha-dihydroprogesterone and 20alpha-dihydroprogesterone, with
Topics: 20-alpha-Dihydroprogesterone; 5-alpha-Dihydroprogesterone; Antineoplastic Agents; Breast Neoplasms; Cell Adhesion; Cell Fractionation; Cell Line, Tumor; Cell Membrane; Cell Proliferation; Cycloheximide; Dactinomycin; Down-Regulation; Estradiol; Female; Humans; Progesterone; Receptors, Estradiol; Receptors, Progesterone; Up-Regulation | 2005 |